Suppr超能文献

唾液腺腺样囊性癌的全基因组测序

Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.

作者信息

Rettig Eleni M, Talbot C Conover, Sausen Mark, Jones Sian, Bishop Justin A, Wood Laura D, Tokheim Collin, Niknafs Noushin, Karchin Rachel, Fertig Elana J, Wheelan Sarah J, Marchionni Luigi, Considine Michael, Ling Shizhang, Fakhry Carole, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Ha Patrick K, Agrawal Nishant

机构信息

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Institute for Basic Biomedical Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Cancer Prev Res (Phila). 2016 Apr;9(4):265-74. doi: 10.1158/1940-6207.CAPR-15-0316. Epub 2016 Feb 9.

Abstract

Adenoid cystic carcinomas (ACC) of the salivary glands are challenging to understand, treat, and cure. To better understand the genetic alterations underlying the pathogenesis of these tumors, we performed comprehensive genome analyses of 25 fresh-frozen tumors, including whole-genome sequencing and expression and pathway analyses. In addition to the well-described MYB-NFIB fusion that was found in 11 tumors (44%), we observed five different rearrangements involving the NFIB transcription factor gene in seven tumors (28%). Taken together, NFIB translocations occurred in 15 of 25 samples (60%, 95% CI, 41%-77%). In addition, mRNA expression analysis of 17 tumors revealed overexpression of NFIB in ACC tumors compared with normal tissues (P = 0.002). There was no difference in NFIB mRNA expression in tumors with NFIB fusions compared with those without. We also report somatic mutations of genes involved in the axonal guidance and Rho family signaling pathways. Finally, we confirm previously described alterations in genes related to chromatin regulation and Notch signaling. Our findings suggest a separate role for NFIB in ACC oncogenesis and highlight important signaling pathways for future functional characterization and potential therapeutic targeting.

摘要

涎腺腺样囊性癌(ACC)在理解、治疗和治愈方面都具有挑战性。为了更好地了解这些肿瘤发病机制背后的基因改变,我们对25个新鲜冷冻肿瘤进行了全面的基因组分析,包括全基因组测序、表达分析和通路分析。除了在11个肿瘤(44%)中发现的已被充分描述的MYB-NFIB融合外,我们在7个肿瘤(28%)中观察到涉及NFIB转录因子基因的5种不同重排。总体而言,25个样本中有15个(60%,95%置信区间,41%-77%)发生了NFIB易位。此外,对17个肿瘤的mRNA表达分析显示,与正常组织相比,ACC肿瘤中NFIB表达上调(P = 0.002)。有NFIB融合的肿瘤与没有NFIB融合的肿瘤在NFIB mRNA表达上没有差异。我们还报告了轴突导向和Rho家族信号通路相关基因的体细胞突变。最后,我们证实了先前描述的与染色质调控和Notch信号相关基因的改变。我们的研究结果表明NFIB在ACC肿瘤发生中具有独立作用,并突出了未来功能表征和潜在治疗靶点的重要信号通路。

相似文献

1
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma.
Cancer Prev Res (Phila). 2016 Apr;9(4):265-74. doi: 10.1158/1940-6207.CAPR-15-0316. Epub 2016 Feb 9.
2
Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.
5
MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions.
Crit Rev Oncol Hematol. 2022 Aug;176:103745. doi: 10.1016/j.critrevonc.2022.103745. Epub 2022 Jun 20.
6
MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Laryngoscope. 2015 Sep;125(9):E292-9. doi: 10.1002/lary.25356. Epub 2015 May 11.
8
Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
Mod Pathol. 2011 Sep;24(9):1169-76. doi: 10.1038/modpathol.2011.86. Epub 2011 May 13.
9
Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
Odontology. 2018 Jul;106(3):238-244. doi: 10.1007/s10266-017-0326-1. Epub 2017 Dec 14.
10
MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
Histopathology. 2017 Nov;71(5):823-834. doi: 10.1111/his.13281. Epub 2017 Aug 16.

引用本文的文献

1
Adenoid cystic carcinoma of the Bartholin's gland: Two case reports and review of literature.
World J Clin Cases. 2025 Sep 16;13(26):108052. doi: 10.12998/wjcc.v13.i26.108052.
2
Molecular pathology of adenoid cystic carcinoma.
Histol Histopathol. 2025 Oct;40(10):1519-1528. doi: 10.14670/HH-18-915. Epub 2025 Apr 2.
3
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands.
J Exp Clin Cancer Res. 2025 Jan 11;44(1):11. doi: 10.1186/s13046-024-03270-x.
4
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial.
EClinicalMedicine. 2024 Dec 10;79:102991. doi: 10.1016/j.eclinm.2024.102991. eCollection 2025 Jan.
5
Adenoid cystic carcinoma: insights from molecular characterization and therapeutic advances.
MedComm (2020). 2024 Sep 11;5(9):e734. doi: 10.1002/mco2.734. eCollection 2024 Sep.
6
Molecular Analysis of Salivary and Lacrimal Adenoid Cystic Carcinoma.
Cancers (Basel). 2024 Aug 17;16(16):2868. doi: 10.3390/cancers16162868.
9
A Review of the Molecular Landscape of Adenoid Cystic Carcinoma of the Lacrimal Gland.
Int J Mol Sci. 2023 Sep 6;24(18):13755. doi: 10.3390/ijms241813755.
10
Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications.
Front Oncol. 2023 Jul 5;13:1191218. doi: 10.3389/fonc.2023.1191218. eCollection 2023.

本文引用的文献

1
Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.
3
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.
Oncotarget. 2015 Nov 10;6(35):37117-34. doi: 10.18632/oncotarget.5076.
4
Approaches of targeting Rho GTPases in cancer drug discovery.
Expert Opin Drug Discov. 2015;10(9):991-1010. doi: 10.1517/17460441.2015.1058775. Epub 2015 Jun 18.
5
Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
Cancer Prev Res (Phila). 2015 Apr;8(4):287-95. doi: 10.1158/1940-6207.CAPR-14-0366. Epub 2015 Jan 29.
6
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Nature. 2015 Jan 29;517(7536):576-82. doi: 10.1038/nature14129.
7
limma powers differential expression analyses for RNA-sequencing and microarray studies.
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.
9
Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors.
Nat Genet. 2014 Nov;46(11):1170-2. doi: 10.1038/ng.3116. Epub 2014 Oct 12.
10
Slit/Robo pathway: a promising therapeutic target for cancer.
Drug Discov Today. 2015 Jan;20(1):156-64. doi: 10.1016/j.drudis.2014.09.008. Epub 2014 Sep 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验